findmyKOL
Clinical trialNCT04190862RecruitingPhase 1Interventional

E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

SponsorWeill Medical College of Cornell UniversityEnrollment39Anal Fistula
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine if endothelial cells derived from human umbilical vein are safe for use in conjunction with fistulotomy for the treatment of simple anal fistulas. Endothelial cells are a special kind of cell in the body that line the inside surface of blood vessels. The goal of the study is to evaluate the preliminary safety of human umbilical vein cells in anal fistula healing.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Weill Cornell Medical College - Newyork-Presbyterian Hospital

    New York, New York, United States

    Heather Yeo, MDJeffrey Milsom, MDKelly Garrett, MDLea Lowenfeld, MDMehraneh Jafari, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

E-CEL UVEC
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Jan 2020
Primary completion
30 Sept 2026
Completion
30 Jun 2032
Last update posted
18 Nov 2025
Registered enrollment
39
Registry id
NCT04190862

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.